Physician profile
Eboni D Ogunbekun
NPI 1588224299
$693.20
in general payments reported to CMS, 2019-2025
11 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.56 · 2023: $302 · 2024: $174 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $145.03 | 2023-2024 | Wegovy |
| Myriad Women'S Health, INC. | $135.76 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $124.47 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Fluent Fluid Management System, Acessa Provu System |
| Astellas Pharma US INC | $89.51 | 2024 | Veozah |
| Smith+Nephew, INC. | $80.14 | 2022 | |
| Evofem Biosciences, INC. | $33.74 | 2024 | |
| Abbvie INC. | $25.59 | 2023 | |
| Aspira Women'S Health INC | $15.81 | 2024 | Ova1 |
| Sumitomo Pharma America, INC. | $15.81 | 2023 | Myfembree |
| Shield Therapeutics INC | $14.92 | 2024 | |
| Organon LLC | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eboni Ogunbekun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.